Trial intelligence / Profile preview

Helicobacter pylori eradication therapy influencing clinical outcomes in Parkinson disease

TCTR20221029004Phase 4Completed

Sponsor
Ramathibodi Hospital, Mahidol University
Start
Oct 2022
Countries
1
01

Overview

Phase 4, randomised trial in Parkinson's disease (PD) and Helicobacter pylori infection, sponsored by Ramathibodi Hospital, Mahidol University. Started Oct 2022; status: completed.

02

Conditions

Parkinson's disease (PD)Helicobacter pylori infection

Beyond the preview

Go deeper on TCTR20221029004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221029004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call